^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Cantabilin (4-methylumbelliferone)

    i
    Other names: 4-MU, 7-hydroxy-4-methylcoumarin
    Company:
    UAB University - Birmingham
    Drug class:
    Hyaluronic acid synthase inhibitor
    over2years
    Investigation of H01 in Adults With Pulmonary Hypertension Including Interstitial Lung Disease (The SATURN Study). (clinicaltrials.gov)
    P2, N=16, Completed, Stanford University | Active, not recruiting --> Completed
    Trial completion
    |
    Cantabilin (4-methylumbelliferone)